People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DisperSol Technologies, LLC | — | Pharmaceuticals | Series B | $37.0M | $143.8M | 2016 |
| Particle Dynamics Holdings, Inc. | — | Other Health Care | Series B | $30.9M | $140.6M | 2025 |
Shaun Kirkpatrick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shaun Kirkpatrick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Samberg | 1 | 14 |
| Dustin Smith | 1 | 6 |
| Derek Hennecke | 1 | 4 |
| Matthew Reber | 1 | 3 |
| Edward R. Hobart | 1 | 2 |
| Michael Caspani | 1 | 2 |
| Edward Hobart | 1 | 2 |
| Michael Kanan | 1 | 1 |
| James D. Mack | 1 | 1 |
| Shaun M. Kirkpatrick | 1 | 1 |
| Edward M. Rudnic, Ph.D. | 1 | 1 |
| Jeffrey D. Samberg | 1 | 1 |
| Gershon Yaniv | 1 | 1 |
| Chris D. Brough | 1 | 1 |
| Gershon D. Yaniv | 1 | 1 |
| James Mack | 1 | 1 |
| Nicolas Fortin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.